Jacques Rachelle Suzanne
CIK 0001772610
Chief Executive OfficerDirector
Filings
15
Latest May 21, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | -6.6% | +0.9% | +45.2% | -73.5% |
| 90 days | 4 | 50% | +15.3% | +2.3% | +60.6% | -4.2% |
| 180 days | 4 | 50% | -33.9% | -2.1% | +60.2% | -191.4% |
| 365 days | 3 | 67% | -16.1% | +67.9% | +75.9% | -192.2% |
Issuers
Companies where Jacques Rachelle Suzanne has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QURE | Uniqure N.V. | 8 | Jun 24, 2025 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 6 | May 21, 2026 |
| AKTX | Akari Therapeutics PLC | 1 | Apr 30, 2024 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|